T2 Biosystems, Inc. (TTOO) is a publicly traded company in the Unknown sector. Across all available filings, 43 corporate insiders have executed 508 transactions totaling $80.9M, demonstrating a bullish sentiment with $38.6M in net insider flow. The most recent transaction on Sep 13, 2024 involved a sale of 55 shares valued at $133.
No significant insider buying has been recorded for TTOO in the recent period.
No significant insider selling has been recorded for TTOO in the recent period.
Based on recent SEC filings, insider sentiment for TTOO is bullish with an Insider Alignment Score of 74/100 and a net flow of $38.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at T2 Biosystems, Inc. (TTOO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 43 insiders are actively trading TTOO stock, having executed 508 transactions in the past 90 days. The most active insider is Advisors, L.l.c. Mbd (Executive), who has made 3 transactions totaling $16.8M.
Get notified when executives and directors at TTOO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | B. Elsbree David | Executive | Sale | 55 | $2.42 | $133 | |
| May 9, 2024 | III L.p. Crg Partners | Executive | Conversion | 108,752 | $N/A | $0 | |
| May 9, 2024 | III L.p. Crg Partners | Executive | Conversion | 1,716,048 | $N/A | $0 | |
| May 3, 2024 | III -. Parallel Fund (a) L.p. Crg Partners | Executive | Award | 129,629 | $N/A | $0 | |
| May 3, 2024 | III -. Parallel Fund (a) L.p. Crg Partners | Executive | Award | 648,139 | $N/A | $0 | |
| May 3, 2024 | III -. Parallel Fund (a) L.p. Crg Partners | Executive | Award | 2,001,514 | $N/A | $0 | |
| May 3, 2024 | III -. Parallel Fund (a) L.p. Crg Partners | Executive | Award | 1,565,445 | $N/A | $0 | |
| May 3, 2024 | III -. Parallel Fund (a) L.p. Crg Partners | Executive | Award | 403,608 | $N/A | $0 | |
| Apr 12, 2024 | III (cayman) Unlev Aiv I. L.p. Crg Partners | Executive | Award | 424,716 | $N/A | $0 | |
| Apr 12, 2024 | III (cayman) Unlev Aiv I. L.p. Crg Partners | Executive | Award | 1,647,315 | $N/A | $0 | |
| Apr 12, 2024 | III (cayman) Unlev Aiv I. L.p. Crg Partners | Executive | Award | 682,036 | $N/A | $0 | |
| Apr 12, 2024 | III (cayman) Unlev Aiv I. L.p. Crg Partners | Executive | Award | 390,142 | $N/A | $0 | |
| Apr 12, 2024 | III (cayman) Unlev Aiv I. L.p. Crg Partners | Executive | Award | 136,409 | $N/A | $0 | |
| Feb 24, 2024 | M. Sprague John | Executive | Option Exercise | 29 | $N/A | $0 | |
| Feb 24, 2024 | Terrence Gibbs Michael | Executive | Option Exercise | 29 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 49 | $59.8M | 72.2% |
Sale(S) | 245 | $21.1M | 25.5% |
Exercise(M) | 147 | $1.0M | 1.2% |
Payment(F) | 23 | $917.7K | 1.1% |
Conversion(C) | 15 | $0 | 0.0% |
Award(A) | 27 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at T2 Biosystems, Inc. are accumulating shares at an accelerated pace. With 43 insiders making 508 transactions totaling $59.8M in purchases versus $21.1M in sales, the net buying activity of $38.6M signals strong executive confidence. Advisors, L.l.c. Mbd (Executive) leads the buying activity with $16.8M in transactions across all time.